Liver function tests are now required less often for patients taking Actos (pioglitazone) or Avandia (rosiglitazone)

September 2004

Liver function tests are now required less often for patients taking Actos (pioglitazone) or Avandia (rosiglitazone).

The serious hepatotoxicity caused by the first glitazone, Rezulin, led to strict liver monitoring for the other glitazones.

Liver enzymes were recommended every 2 months for the first year for Actos and Avandia.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote